HAVN Life Sciences Inc.

HAVN Life to Present at Upcoming LD Micro Invitational XII

HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022

HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics

HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness

HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies

HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility

7 Stocks to Buy if You Think Alternative Therapies Are the Future

HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe

HAVN Life Signs Exclusive Supply Agreement With Cube Psytech

HAVN Life is Looking for a Safe Haven to Mental Health Through Psychedelic Medicine

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches

Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit

Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers

Havn Labs Jamaica Facility Now Fully Operational

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies